Conference abstractPublished 13 Jun 2016
New technology for toughened and reinforced PLLA with phosphorous glass to form nanocomposites for bioresorbable vascular scaffold applications
University of Cambridge, United Kingdom
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Bare Metal Stents (BMS) and Drug Eluting Stents (DES) are the established technologies in cardiovascular therapy. There are, however, clinical complications associated with these technologies, such as, early stage restenosis, very late thrombosis and risk associated with revision surgery. In light of these challenges research focus has turned to the development of bioresorbable vascular scaffold (BVS) technologies. Abbott has developed one PLLA biodegradable polymeric stent that is made from PLLA. One drawback of the PLLA is brittle because its glass transition is about 65 C. To overcome the problem, we firstly toughened PLLA then reinforce the materials by employing resorbable bioglass. Through a systematic study involving 14 organisations, we have successfully developed a family of toughened and reinforced polyesters with controlled degradation rate. This presentation will report the development of a reinforced resorbable therapeutic cardiovascular stent application to address the known limitations of cardiovascular technologies. We aim to deliver a bioresorbable stent with intrinsic toughness for handling and deployment via balloon angioplasty, radial strength, controlled drug-release technology to suppress restenosis and surface functionalisation to promote endothelialisation to reduce risk of thrombosis. We present the novel synthetic polymer-glass composites developed as candidate stent-core materials and describe both their preparation and the characterisation of their mechanical behaviour, in vitro degradation and cytocompatibility.
Subjects
CardiologyNanotechnologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectCardiology
- SubjectNanotechnology
- BylineArticles whose byline prints “Xiang Zhang”
